Please use this identifier to cite or link to this item: 10.3390/microorganisms9071420
Title: Clinical characteristics of patients with tick-borne encephalitis (Tbe) : A European multicentre study from 2010 to 2017
Authors: Kohlmaier, Benno
Schweintzger, Nina A.
Sagmeister, Manfred G.
Švendová, Vendula
Kohlfürst, Daniela S.
Sonnleitner, Astrid
Leitner, Manuel
Berghold, Andrea
Schmiedberger, Erich
Fazekas, Franz
Pichler, Alexander
Rejc-Marko, Jana
Růžek, Daniel
Dufková, Lucie
Čejková, Darina
Husa, Petr
Pýchová, Martina
Krbková, Lenka
Chmelík, Václav
Štruncová, Věra
Zavadska, Dace
Karelis, Guntis
Mickiene, Aukse
Zajkowska, Joanna
Bogovič, Petra
Strle, Franc
Zenz, Werner
Department of Paediatrics
Rīga Stradiņš University
Keywords: Central paresis;Meningomyelitis;Peripheral paresis;Tick-borne encephalitis;Vaccine-preventable disease;3.2 Clinical medicine;3.3 Health sciences;1.1. Scientific article indexed in Web of Science and/or Scopus database;Microbiology;Microbiology (medical);Virology;SDG 3 - Good Health and Well-being
Issue Date: Jul-2021
Citation: Kohlmaier , B , Schweintzger , N A , Sagmeister , M G , Švendová , V , Kohlfürst , D S , Sonnleitner , A , Leitner , M , Berghold , A , Schmiedberger , E , Fazekas , F , Pichler , A , Rejc-Marko , J , Růžek , D , Dufková , L , Čejková , D , Husa , P , Pýchová , M , Krbková , L , Chmelík , V , Štruncová , V , Zavadska , D , Karelis , G , Mickiene , A , Zajkowska , J , Bogovič , P , Strle , F & Zenz , W 2021 , ' Clinical characteristics of patients with tick-borne encephalitis (Tbe) : A European multicentre study from 2010 to 2017 ' , Microorganisms , vol. 9 , no. 7 , 1420 . https://doi.org/10.3390/microorganisms9071420
Abstract: Tick-borne encephalitis (TBE) virus is a major cause of central nervous system infections in endemic countries. Here, we present clinical and laboratory characteristics of a large international cohort of patients with confirmed TBE using a uniform clinical protocol. Patients were recruited in eight centers from six European countries between 2010 and 2017. A detailed description of clinical signs and symptoms was recorded. The obtained information enabled a reliable classification in 553 of 555 patients: 207 (37.3%) had meningitis, 273 (49.2%) meningoencephalitis, 15 (2.7%) meningomyelitis, and 58 (10.5%) meningoencephalomyelitis; 41 (7.4%) patients had a peripheral paresis of extremities, 13 (2.3%) a central paresis of extremities, and 25 (4.5%) had single or multiple cranial nerve palsies. Five (0.9%) patients died during acute illness. Outcome at discharge was recorded in 298 patients. Of 176 (59.1%) patients with incomplete recovery, 80 (27%) displayed persisting symptoms or signs without recovery expectation. This study provides further evidence that TBE is a severe disease with a large proportion of patients with incomplete recovery. We suggest monitoring TBE in endemic European countries using a uniform protocol to record the full clinical spectrum of the disease.
Description: Funding Information: Conflicts of Interest: W.Z. received financial support from GSK, Pfizer, Merck, and Sanofi for organizing the “Graz Vaccination Day”. Funding Information: Funding: This study was financially supported by Land Steiermark (Office of the Regional Government of Styria, Department of Health Care and Science, Unit of Science and Research, Austria). D.R., L.K. and M.P. were supported by the Czech Ministry of Health (grant No. NV19-05-00457). P.B. and F.S. were supported by the Slovenian Research Agency (grant. No P3-0296). Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
DOI: 10.3390/microorganisms9071420
Appears in Collections:Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure

Files in This Item:
File SizeFormat 
microorganisms_09_01420.pdf509 kBAdobe PDFView/Openopen_acces_unlocked


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.